Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,271 public trials 1,197 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, not recruiting

Study of Intravenous (IV) ABBV-637 Alone or in Combination With IV Docetaxel/Osimertinib to Assess Adverse Events and Change in Disease Activity in Adult Participants With Relapsed/Refractory (R/R) Solid Tumors

NCT04721015

Conditions
Advanced Solid Tumors Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +9 more
Locations
  • Dana-Farber Cancer Institute /ID# 231209 Boston, Massachusetts, United States
  • Washington University-School of Medicine /ID# 225698 St Louis, Missouri, United States
  • Carolina BioOncology Institute /ID# 225358 Huntersville, North Carolina, United States
  • Lifespan Cancer Institute at Rhode Island Hospital /ID# 226145 Providence, Rhode Island, United States
View all 33 locations
View Trial Details
Active, not recruiting

Study to Compare Furmonertinib to Platinum-Based Chemotherapy for Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations (FURVENT)

NCT05607550

Conditions
Advanced Non-Small Cell Lung Cancer, Bronchial Neoplasms, Carcinoma, Bronchogenic, +10 more
Locations
  • Arrivent Investigative Site Daphne, Alabama, United States
  • Arrivent Investigative Site Yuma, Arizona, United States
  • Arrivent Investigative Site Fayetteville, Arkansas, United States
  • Arrivent Investigative Site Beverly Hills, California, United States
View all 208 locations
View Trial Details
Active, not recruiting

HER3-DXd (Patritumab Deruxtecan; U3-1402) in Combination With Osimertinib in Subjects With Locally Advanced or Metastatic EGFR-mutated Non-Small Cell Lung Cancer

NCT04676477

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • UCLA Santa Monica, California, United States
  • Yale University School of Medicine - Yale-New Haven Hospital New Haven, Connecticut, United States
  • Georgetown University Medical Center Washington D.C., District of Columbia, United States
  • Northwestern University Feinberg School of Medicine Chicago, Illinois, United States
View all 31 locations
View Trial Details
Active, not recruiting

Testing the Effects of MK-3475 (Pembrolizumab) With or Without the Usual Chemotherapy Treatment for Patients 70 Years of Age and Older With Advanced Non-small Cell Lung Cancer

NCT04533451

Conditions
Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +19 more
Locations
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
  • Anchorage Radiation Therapy Center Anchorage, Alaska, United States
  • Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
  • Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
View all 505 locations
View Trial Details
Active, not recruiting

Phase 2 Study of Dacomitinib in NSCLC

NCT04027647

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +12 more
Locations
  • Prince of Wales Hospital Hong Kong
  • Sarawak General Hospital Kuching, Sarawak, Malaysia
  • University Malaya Medical Centre Kuala Lumpur, Malaysia
  • Beacon Hospital Petaling Jaya, Malaysia
View Trial Details

Related conditions